Surmounting Barriers to Adopting Biosimilar Therapies: Strategies for Achieving Goals of the Biologics Price Competition and Innovation Act is organized by Prime Education, LLC.
Release Date: May 30, 2019
Expiration Date: May 29, 2020
Physicians and Pharmacists
Continuing Education Credits:
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Physician Credit Designation Statement
PRIME designates this Enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
This curriculum has been approved for 1.0 contact hour (0.1 CEUs) by PRIME.
Formidable barriers to biosimilar adoption have been identified and discussed extensively in the literature. However, studies are lacking to identify actionable strategies for overcoming these barriers, specifically to achieve goals set by the Biologics Price Competition and Innovation Act (BPCIA). This accredited CE webcast features unique insights from a recent survey study conducted by the Academy of Managed Care Pharmacy (AMCP) and PRIME Education, which assessed the perceptions of such strategies among managed care and specialty pharmacy professionals. Led by faculty with deep expertise in biosimilar therapies and managed care pharmacy who were involved in the study, the webcast features constructive dialogues on collaborative strategies for advancing the evidence-based adoption of biosimilar therapies.
Additional details will be posted as soon as they are available.
Pharmacy and Medicine, Biotechnology